EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 0.8650
+0.1550 (21.83%)
At close: Jun 3, 2026
EXACT Therapeutics AS Revenue
In the year 2025, EXACT Therapeutics AS had annual revenue of 59.00K NOK. EXACT Therapeutics AS had revenue of 59.00K in the half year ending December 31, 2025.
Revenue
59.00K
Revenue Growth
n/a
P/S Ratio
927.51
Revenue / Employee
5.36K
Employees
11
Market Cap
54.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 59.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 4.46K | -450.06K | -99.02% |
| Dec 31, 2022 | 454.52K | 402.52K | 774.07% |
| Dec 31, 2021 | 52.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 128.37M |
| Arctic Bioscience AS | 42.62M |
| Oncoinvent ASA | 28.07M |
| SoftOx Solutions AS | 15.58M |
| Aqua Bio Technology ASA | 7.53M |
| Nykode Therapeutics AS | 5.42M |
| Thor Medical ASA | 839.00K |
| Lytix Biopharma ASA | 377.00K |
EXACT Therapeutics AS News
- 2 months ago - EXACT Therapeutics AS Annual report: H2 2025 - Filings
- 4 months ago - EXACT Therapeutics AS Transcript: Investor update - Transcripts
- 4 months ago - EXACT Therapeutics AS Slides: Investor update - Filings
- 4 months ago - EXACT Therapeutics AS Slides: Company presentation - Filings
- 6 months ago - EXACT Therapeutics AS Slides: DNB Carnegie Nordic Healthcare Conference Presentation - Filings
- 9 months ago - EXACT Therapeutics AS Quarterly report: H1 2025 - Filings